Study of LQT-1213 on QTc-induced Prolongation in Healthy Adult Subjects (Part1) and on Congenital Long QT in Patients Diagnosed With Type 2 or 3 Long QT Syndrome (Part 2).
Clinical trial NCT05906732 · TERMINATED
Trial details
- NCT number
- NCT05906732
- Sponsor
- Thryv Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-12
- Primary completion
- 2024-05-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.